{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:46:13Z","timestamp":1775925973824,"version":"3.50.1"},"posted":{"date-parts":[[2026,4,9]]},"group-title":"Public and Global Health","reference-count":24,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Biologically defined sepsis subtypes have been identified in low- and middle-income countries (LMICs), but limited access to molecular diagnostics challenges broader evaluation and implementation in resource-limited settings. We assessed whether models including bedside clinical and rapid microbiologic data could accurately stratify Ugandan adults with sepsis by molecular subtype.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Secondary analysis of two prospective observational sepsis cohorts, testing bedside-adaptable classifier models against transcriptomic and proteomic subtype assignments.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Entebbe Regional Referral Hospital (urban) and Tororo General Hospital (rural), Uganda.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Adults (\u226518 years) hospitalized with sepsis, with available transcriptomic (N=355) and\/or proteomic (N=495) profiling enabling subtype assignment.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>None.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Measurements and Main Results<\/jats:title>\n                  <jats:p>\n                    Using data from two prospective cohorts (RESERVE-U-2-TOR and RESERVE-U-1-EBB), we evaluated bedside-adaptable models against Uganda-derived molecular sepsis subtypes, and, secondarily, against molecular subtypes and axes derived in high-income countries. In RESERVE-U-2-TOR, clinical models including demographics and bedside physiological variables demonstrated moderate discrimination for transcriptomic and proteomic subtype assignment (AUROC 0.75 [95% CI, 0.69\u20130.81] and 0.73 [0.66\u20130.80], respectively) with strong calibration (Integrated Calibration Index [E\n                    <jats:sub>avg<\/jats:sub>\n                    ] \u22640.015 for both models). Adding rapid diagnostic results for HIV, malaria, and tuberculosis produced similar performance (AUROC 0.76 and 0.74; E\n                    <jats:sub>avg<\/jats:sub>\n                    \u22640.016). In RESERVE-U-1-EBB, discrimination for clinical and clinico-microbiological models was more variable (AUROC range 0.63\u20130.75) while calibration remained acceptable (E\n                    <jats:sub>avg<\/jats:sub>\n                    \u22640.053). Performance was similar when models were evaluated against molecular sepsis frameworks derived in high-income countries, with acceptable calibration and moderate discrimination.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Bedside-adaptable clinical models, with or without rapid microbiologic testing, demonstrated acceptable calibration but only modest discrimination for molecular sepsis subtype assignment in Uganda. Expanding laboratory capacity and access to scalable, low-cost molecular biomarker assays will be necessary to advance precision sepsis care in LMIC settings.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Key Points<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Question<\/jats:title>\n                    <jats:p>Among adults hospitalized with sepsis in a resource-limited setting, can bedside clinical variables, alone or combined with rapid pathogen diagnostics, accurately stratify molecular sepsis subtype assignments?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>In two prospective Ugandan sepsis cohorts, bedside clinical and clinico-microbiologic models showed robust calibration but only modest discrimination for classifying Uganda-derived transcriptomic and proteomic subtypes. Models also achieved moderate performance for stratifying high-income-country-derived transcriptomic subtypes and immune dysfunction axes, suggesting bedside variables reflect illness severity but incompletely capture underlying molecular signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Meaning<\/jats:title>\n                    <jats:p>Bedside-adaptable models can support reasonably calibrated risk estimation for molecular sepsis stratification in resource-limited settings but lack sufficient discriminatory power to serve as stand-alone tools. These findings support efforts to improve acute-care laboratory capacity and access to scalable molecular biomarker panels, with the goal of enabling precision sepsis care in low- and middle-income countries.<\/jats:p>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.64898\/2026.04.08.26350396","type":"posted-content","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:55:18Z","timestamp":1775757318000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Bedside-Adaptable Models to Predict Molecular Sepsis Subtypes in a Resource-Limited Setting: A Multicenter Analysis from Uganda"],"prefix":"10.64898","author":[{"given":"Barnabas","family":"Bakamutumaho","sequence":"first","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius J.","family":"Lutwama","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Owor","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter James","family":"Eliku","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Namulondo","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kayiwa","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse E.","family":"Ross","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Nsereko","sequence":"additional","affiliation":[{"name":"Entebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Bosco","family":"Nsubuga","sequence":"additional","affiliation":[{"name":"Entebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shinyale","sequence":"additional","affiliation":[{"name":"Entebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignatius","family":"Asasira","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonny","family":"Kiyingi","sequence":"additional","affiliation":[{"name":"Department of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA"},{"name":"Rakai Health Sciences Program, Kalisizo, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Nie","sequence":"additional","affiliation":[{"name":"Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seunghee","family":"Kim-Schulze","sequence":"additional","affiliation":[{"name":"Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Cummings","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA"},{"name":"Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041109151143000_2026.04.08.26350396v1.1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(20)30124-7","article-title":"Subphenotypes in critical care: translation into clinical practice","volume":"8","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","article-title":"Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes","volume":"49","year":"2023","journal-title":"Intensive Care Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.4","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41591-025-03964-5","article-title":"A consensus blood transcriptomic framework for sepsis","volume":"31","year":"2025","journal-title":"Nat Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.5","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","article-title":"A consensus immune dysregulation framework for sepsis and critical illnesses","volume":"31","year":"2025","journal-title":"Nat Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0347OC"},{"key":"2026041109151143000_2026.04.08.26350396v1.8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(21)00461-6","article-title":"Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis","volume":"10","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.9","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis","volume":"13","author":"Global Sepsis Collaborators","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026041109151143000_2026.04.08.26350396v1.10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-025-08047-0","article-title":"Identification of transcriptomic sepsis endotypes in sub-Saharan Africa: derivation, validation, and global alignment in two Ugandan cohorts","volume":"51","year":"2025","journal-title":"Intensive Care Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/rccm.202407-1394OC","article-title":"Unsupervised Classification of the Host Response Identifies Dominant Pathobiological Signatures of Sepsis in Sub-Saharan Africa","volume":"211","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2026041109151143000_2026.04.08.26350396v1.13","doi-asserted-by":"crossref","first-page":"e0264517","DOI":"10.1371\/journal.pone.0264517","article-title":"Emergency care of sepsis in sub-Saharan Africa: Mortality and non-physician clinician management of sepsis in rural Uganda from 2010 to 2019","volume":"17","year":"2022","journal-title":"PLoS One"},{"key":"2026041109151143000_2026.04.08.26350396v1.14","doi-asserted-by":"crossref","first-page":"e2136398","DOI":"10.1001\/jamanetworkopen.2021.36398","article-title":"Performance Assessment of the Universal Vital Assessment Score vs Other Illness Severity Scores for Predicting Risk of In-Hospital Death Among Adult Febrile Inpatients in Northern Tanzania, 2016-2019","volume":"4","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026041109151143000_2026.04.08.26350396v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.6229"},{"key":"2026041109151143000_2026.04.08.26350396v1.16","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2501-y"},{"key":"2026041109151143000_2026.04.08.26350396v1.17","unstructured":"World Health Organization. Uganda IMAI district clinician manual: guidelines for the management of common illnesses. Geneva and Kampala: 2014. Available at: https:\/\/www.imaialliance.org\/allresources\/uganda-imai-district-clinician-manual."},{"key":"2026041109151143000_2026.04.08.26350396v1.18","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1002\/sim.8281","article-title":"The Integrated Calibration Index (ICI) and related metrics for quantifying the calibration of logistic regression models","volume":"38","year":"2019","journal-title":"Stat Med"},{"key":"2026041109151143000_2026.04.08.26350396v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.q902"},{"key":"2026041109151143000_2026.04.08.26350396v1.20","doi-asserted-by":"crossref","first-page":"104394","DOI":"10.1016\/j.ebiom.2022.104394","article-title":"Sepsis biomarkers and diagnostic tools with a focus on machine learning","volume":"86","year":"2022","journal-title":"EBioMedicine"},{"key":"2026041109151143000_2026.04.08.26350396v1.21","doi-asserted-by":"crossref","first-page":"104348","DOI":"10.1016\/j.ebiom.2022.104348","article-title":"Equitable endotyping is essential to achieve a global standard of precise, effective, and locally-relevant sepsis care","volume":"86","year":"2022","journal-title":"EBioMedicine"},{"key":"2026041109151143000_2026.04.08.26350396v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115181"},{"key":"2026041109151143000_2026.04.08.26350396v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0199-3"},{"key":"2026041109151143000_2026.04.08.26350396v1.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2086SO"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.04.08.26350396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:15:22Z","timestamp":1775924122000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.04.08.26350396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":24,"URL":"https:\/\/doi.org\/10.64898\/2026.04.08.26350396","relation":{},"subject":[],"published":{"date-parts":[[2026,4,9]]},"subtype":"preprint"}}